These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32142862)

  • 61. Levodopa Improves Behavioral Deficits of Mice with Parkinson's Disease Symptoms via Curbing NLRP3 Inflammasome Activation and Enhancing Tyrosine Hydroxylase Levels in the Striatum and Substantia Nigra.
    Chen X; Wang Z; Yang W; Fu Y
    J Integr Neurosci; 2024 Jan; 23(1):2. PubMed ID: 38287845
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of striatal pre-enkephalin overexpression in the basal ganglia of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Bissonnette S; Muratot S; Vernoux N; Bezeau F; Calon F; Hébert SS; Samadi P
    Eur J Neurosci; 2014 Jul; 40(2):2406-16. PubMed ID: 24750443
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U; Ramsay KA; Jiang H; Jackson-Lewis V; Donaldson D; Fernando S; Ferreira M; Przedborski S
    Exp Neurol; 1994 Apr; 126(2):195-204. PubMed ID: 7925820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
    Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
    Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration.
    Baydyuk M; Nguyen MT; Xu B
    Exp Neurol; 2011 Mar; 228(1):118-25. PubMed ID: 21192928
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.
    Khakimova GR; Kozina EA; Kucheryanu VG; Ugrumov MV
    Mol Neurobiol; 2017 Jul; 54(5):3618-3632. PubMed ID: 27194433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
    Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K
    Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's disease.
    Janis KL; Brennan RT; Drolet RE; Behrouz B; Kaufman SK; Lookingland KJ; Goudreau JL
    J Alzheimers Dis; 2008 Sep; 15(1):97-107. PubMed ID: 18780970
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.
    Dutta D; Kundu M; Mondal S; Roy A; Ruehl S; Hall DA; Pahan K
    Neurobiol Dis; 2019 Dec; 132():104575. PubMed ID: 31445159
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice.
    Hwang CJ; Choi DY; Jung YY; Lee YJ; Yun JS; Oh KW; Han SB; Oh S; Park MH; Hong JT
    Horm Behav; 2016 Apr; 80():19-29. PubMed ID: 26836768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning.
    Goldberg NR; Hampton T; McCue S; Kale A; Meshul CK
    J Neurosci Res; 2011 Oct; 89(10):1698-706. PubMed ID: 21748776
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging.
    Date I; Yoshimoto Y; Imaoka T; Miyoshi Y; Gohda Y; Furuta T; Asari S; Ohmoto T
    Brain Res; 1993 Sep; 621(1):150-4. PubMed ID: 8106113
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.
    Otto D; Unsicker K
    J Neurosci; 1990 Jun; 10(6):1912-21. PubMed ID: 1972393
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Goldberg NR; Haack AK; Lim NS; Janson OK; Meshul CK
    Neuroscience; 2011 Apr; 180():256-71. PubMed ID: 21335067
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H; Underwood R; Lavalley N; Yacoubian TA
    Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
    Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
    Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Araki T; Muramatsu Y; Tanaka K; Matsubara M; Imai Y
    Neurosci Lett; 2001 Oct; 312(1):50-4. PubMed ID: 11578843
    [TBL] [Abstract][Full Text] [Related]  

  • 79. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
    Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.